Compass Therapeutics, Inc.
CMPX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001738021
In the last 90 days, Compass Therapeutics, Inc. insiders filed 3 open-market purchases and 0 sales; 171 institutions reported holding it in 13F filings for Q3 2026, worth $167.0M in total; no superinvestor holds it.
Superinvestors holding CMPX, Q3 2026
See all superinvestorsNo superinvestor reported holding CMPX in Q3 2026.